Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-04
2007-12-04
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S278000
Reexamination Certificate
active
10258447
ABSTRACT:
A liquid preparation having improved light stability is provided, which comprises an aqueous solution containing sitafloxacin and sodium chloride.
REFERENCES:
patent: 4957922 (1990-09-01), Lammens et al.
patent: 5587386 (1996-12-01), Hayakawa et al.
patent: 0 341 493 (1989-11-01), None
patent: 0470252 (1992-02-01), None
patent: 2044544 (2006-04-01), None
CAS STN Registry for Perfloxacin and ciprofloxacin, p. 1-2.
CA on STN, AN 119:233801, Bails, M. et al., “Pefloxacin Stability in Perfusion Solutions. Effect of Solvent and Filtration”, J. Pharm. Clin., (1991), vol. 10, No. 4, pp. 247-250.
CA on STN, AN 121:163853, Hu, Daode, et al., “Stability of Ofloxacin in Several Transfusion Solutions”, Zhongguo Yiyuan Yaoxue Zazhi, (1994), vol. 14, No. 4, pp. 168-169.
Tetsu Morimura et al., Photoreaction and Active Oxygen Generation by Photosensitization of a New Antibacterial Fluoroquinolone Derivatives, Orbifloxacin, in the Presence of Chloride Ion, Chem. Pharm. Bull. 45(11), (1997), pp. 1828-1832.
M. Bails, et al., The Stability of Pefloxacin in Solution for IV Admixture: Effect of the Solvent and of Filtration, Journal of Pharm. Clin. 1991; 10: pp. 247-250, Paris, France.
D. Hu et al., The Observation on Stability of Ofloxacin Injection in Several Transfusion Fluids, Pharmaceutical Department, Hospital of Xuzhou Medical College, pp. 1-4, Jiangsu Province, Japan.
Mao, Youchang et al., “Stability of 1% ofloxacin injection in several transfusion solutions”, Database CA ′Online! Chemical Abstracts Service, Columbus, Ohio, US, 1997, retrieved rom STN Dataabase accession No. 1997:532254; XP-002366393.
Miyazaki, Shuichi, et al, “In vitro and in vivo evaluation of DU6859a, a new flouroquinolone among injectable antibacterials tested against clinical isolates” Journal of Injection and Chemotherapy, 2(3), 148-155, 1996 XP00906974.
Tomioka, H. et al., “Comparative in Vitro Antimicrobial Activities of the Newly Synthesized Quinolone HSR-903, Sitaflaxocin (DU-6859A), Gatifloxacin (AM-1155), and Levofloxacin Against Mycobacterium Tuberculosis and Mucobacterium Avium Complex” Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, D.D., US, vol. 43, No. 12, Dec. 1999, pp. 3001-3004, XP002941445.
Araki Masanori
Matsukawa Azusa
Nakagami Hiroaki
Daiichi Pharmaceutical Co. Ltd.
Hui San-Ming
Sughrue Mion Pllc.
LandOfFree
Stabilized liquid preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized liquid preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized liquid preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3868562